Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$345000.0.

  • PAVmed's Other Working Capital Changes changed N/A to -$345000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$339000.0, marking a year-over-year change of. This contributed to the annual value of -$832000.0 for FY2024, which is 43821.14% down from last year.
  • According to the latest figures from Q3 2025, PAVmed's Other Working Capital Changes is -$345000.0.
  • PAVmed's Other Working Capital Changes' 5-year high stood at $1.5 million during Q2 2022, with a 5-year trough of -$1.5 million in Q4 2023.
  • In the last 4 years, PAVmed's Other Working Capital Changes had a median value of -$28000.0 in 2022 and averaged -$62142.9.
  • Per our database at Business Quant, PAVmed's Other Working Capital Changes crashed by 26288.34% in 2024 and then soared by 19735.1% in 2025.
  • Over the past 4 years, PAVmed's Other Working Capital Changes (Quarter) stood at -$960000.0 in 2022, then plummeted by 57.4% to -$1.5 million in 2023, then soared by 83.26% to -$253000.0 in 2024, then plummeted by 36.36% to -$345000.0 in 2025.
  • Its last three reported values are -$345000.0 in Q3 2025, $449000.0 for Q2 2025, and -$190000.0 during Q1 2025.